After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, GALT falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Galectin Therapeutics Inc is $76.64M. A total of 0.7 million shares were traded on the day, compared to an average of 703.75K shares.
In the most recent transaction, Shlevin Harold H. bought 6,500 shares of GALT for 1.16 per share on Dec 30 ’24. After the transaction, the Director now owns 15,206 company shares. In a previous transaction on Dec 23 ’24, Jamil Khurram sold 13,654 shares at 0.88 per share. GALT shares that Chief Medical Officer owns now total 26,346.
Among the insiders who sold shares, LEWIS JOEL disposed of 56,000 shares on Dec 23 ’24 at a per-share price of $0.89. This resulted in the President and CEO holding 897,012 shares of GALT after the transaction. In another insider transaction, CALLICUTT JACK W sold 40,000 shares at $0.89 per share on Dec 23 ’24. Company shares held by the Chief Financial Officer now total 7,614.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, GALT has a high of $4.27 and a low of $0.73.
As of this writing, GALT has an earnings estimate of $0 per share for the current quarter.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. GALT’s latest balance sheet shows that the firm has $39.65M in Cash & Short Term Investments as of fiscal 2021. There were $29.06M in debt and $9.03M in liabilities at the time. Its Book Value Per Share was -$1.52, while its Total Shareholder’s Equity was $2.62M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for GALT is Buy with a score of 3.00.
